Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_assertion type Assertion NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_head.
- NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_assertion wasGeneratedBy ECO_0000203 NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_provenance.
- NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_assertion wasDerivedFrom befree-2016 NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_provenance.
- NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_assertion SIO_000772 23792430 NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_provenance.
- NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_assertion evidence source_evidence_literature NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_provenance.
- NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_assertion description "[Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088106.RApsRetf9hbLUxeHnO4Fu179OS1wai-LMst4dkL3yuNZA130_provenance.